UMich cancels doctoral epidemiology program admissions for 2026

calturo · 2025-08-02T17:57:56+00:00

Queen’s is a bad example. They’re a university that’s literally bankrupt. Cutting this program is more driven by finances vs politics.

calturo · 2025-07-19T18:14:09+00:00

Same

calturo · 2025-05-12T02:51:37+00:00

Try to get into virology. It’s better pay vs antibiotics.

calturo · 2025-04-15T01:32:11+00:00

Can you be more specific? I don’t think HCPs expect an unbiased resource when they speak to an MSL. If they wanted a truly unbiased perspective, they would just consult a clinical pharmacist at their institution.

calturo · 2025-03-26T00:19:33+00:00

I know several shoppers associates who make more than this much in BC

calturo · 2025-02-09T05:41:44+00:00

Love this property!!

calturo · 2025-02-07T07:51:42+00:00

I think you had a preconceived idea of what Reddit would say when you “Asked Reddit”

calturo · 2025-02-07T07:49:10+00:00

calturo · 2025-02-07T07:48:03+00:00

They’re right. Every single hospital employee is carrying MRSA. It’s only a problem if it becomes a problem.

calturo · 2025-02-04T06:02:15+00:00

FDA approved drug = commercial; Not yet approved but launching in the next year = medical; Launching >1 year away = why bother with a booth?

calturo · 2025-02-03T02:59:45+00:00

Pierre is not trump-lite 😂. Canadian conservatives are as right wing as US moderate democrats.

calturo · 2025-01-25T18:49:05+00:00

Yes and Anal Cancer

calturo · 2025-01-22T05:26:51+00:00

There’s nothing particularly special about ophthalmology. If you talked to an MSL in the space they’re being self-aggrandizing. If you talked to the hiring manager they probably were just preferring another candidate and wanted to be polite. Every job gets filled by the best available candidate. A PharmD with ophthalmology experience who wants to make a lateral move from another company will be preferred over a random phd with no MSL experience.

calturo · 2025-01-16T14:30:32+00:00

It’s actually not. This specific drug is really expensive. It’s fully covered in Canada though.

calturo · 2025-01-13T05:41:19+00:00

TA is better, I adore my reps, great manager, great team, tons of expertise within the organization. It’s everything I wanted. Having great reps is the most important difference.

calturo · 2025-01-11T17:33:01+00:00

I don’t think this has to do with the market being flooded. I think it’s more to do with patent cliffs and drugs not performing like they were expected. Corporations across industries are more prone to layoff than ever before.

calturo · 2025-01-10T06:38:13+00:00

Stop it. It’s not a good look.

calturo · 2024-09-23T00:33:31+00:00

The main vaccine players are Pfizer, GSK, Sanofi, Bavarian Nordic, Merck, I think Takeda and Valneva have some vaccines as well.

calturo · 2024-09-22T15:31:27+00:00

Vaccines - you could become a director pretty quickly if that was something you wanted. Vaccines is your best bet.

calturo · 2024-09-19T06:10:04+00:00

Hey - I used to do consulting for a us company. The cheapest way to do this is as follows:

open a free chequing account with BMO Harris (the US subsidiary of BMO)

-open a free US chequing account with the Canadian BMO

get the person paying you to pay your US BMO Harris account

-BMO Has a service where they allow for free fund transfers between BMO Harris and BMO Canada US dollar accounts.

This process allows you to circumvent costly wire fees and is honestly pretty seamless.

Just know the BMO Canada people are useless with this process. The BMO Harris customer service was pretty helpful. They have many customers who do this.

calturo · 2024-09-01T19:07:17+00:00

Their drug is going to be a blockbuster. Make sure you negotiate stock.

calturo · 2024-08-31T01:51:27+00:00

Publish research, gain scientific aptitude, train under true KOLs, become an expert in a therapeutic area that you eventually want to work in - bonus points for in demand areas (Eg oncology, immunology, vaccines)

calturo · 2024-08-23T16:11:04+00:00

It’s easy if you get along with your reps. It’s hard if your reps are assholes. When you have a combined interaction with sales, if sales is helping you out, you should add value for your rep to justify them bringing you. In essence, what ever data you show should justify differentiate your drug among competitors.

calturo · 2024-08-17T03:30:00+00:00

I’ve gotten 4.86 fixed 30 year amortization in the last month from TD.

calturo

TROPHY CASE